Protection from Inflammation, Immunosuppression and Carcinogenesis Induced by UV Radiation in Mice by Topical Pycnogenol®¶
- 1 January 2004
- journal article
- Published by Wiley in Photochemistry and Photobiology
- Vol. 79 (2), 193-198
- https://doi.org/10.1562/0031-8655(2004)079<0193:pfiiac>2.0.co;2
Abstract
Pycnogenol is a standardized extract of the bark of the French maritime pine, Pinus pinaster Ait., that has multiple biological effects, including antioxidant, anti-inflammatory and anticarcinogenic properties. This study describes the effect of topical application of lotions containing Pycnogenol to Skh:hr hairless mice undergoing minimally inflammatory daily exposures to solar-simulated UV radiation (SSUV). We report that concentrations of Pycnogenol of 0.05-0.2% applied to the irradiated dorsal skin immediately after exposure resulted in dose-dependent reduction of the inflammatory sunburn reaction, measured as its edema component. When mice received three consecutive daily exposures of minimally edematous SSUV, their ability to raise a contact hypersensitivity (CHS) reaction was suppressed by 54%. Pycnogenol lotions applied postirradiation reduced this immunosuppression to 22% (0.05% Pycnogenol) and 13% (0.1% Pycnogenol). Furthermore, when CHS was suppressed by 71% with exogenous treatment with cis-urocanic acid, the putative epidermal mediator of photoimmunosuppression, 0.2% Pycnogenol lotion reduced the immunosuppression to 18%. Chronic exposure to SSUV on 5 days/week for 10 weeks induced skin tumors from 11 weeks in both control mice and in mice receiving daily applications of 0.05% Pycnogenol, but tumor appearance was significantly delayed until 20 weeks in mice receiving 0.2% Pycnogenol. Furthermore, whereas 100% of control mice had at least one tumor by 30 weeks, and mice treated with 0.05% Pycnogenol by 33 weeks, the maximum tumor prevalence in mice treated with 0.2% Pycnogenol was significantly reduced to 85%, with some mice remaining tumor free. Average tumor multiplicity was also significantly reduced by 0.2% Pycnogenol, from 5.2 in control mice to 3.5 at 35 weeks. Thus, topical Pycnogenol offered significant and dose-dependent protection from SSUV-induced acute inflammation, immunosuppression and carcinogenesis, when applied to the skin after daily irradiation. Pycnogenol, therefore, in addition to its recognized health benefits in other organs, appears to have potential in providing photoprotection for humans in a complementary role with sunscreens, having demonstrable activity when applied to the skin after, rather than before, UV exposure.This publication has 25 references indexed in Scilit:
- A review of the French maritime pine bark extract (Pycnogenol®), a herbal medication with a diverse clinical pharmacologyInternational journal of clinical pharmacology and therapeutics, 2002
- Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (pinus maritima) bark, pycnogenolFree Radical Biology & Medicine, 1999
- Pycnogenol enhances endothelial cell antioxidant defensesRedox Report, 1997
- Photocarcinogenesis: an overviewJournal of Photochemistry and Photobiology B: Biology, 1997
- Does Exposure to UV Radiation Induce a Shift to a Th‐2‐like Immune Reaction?Photochemistry and Photobiology, 1996
- Preventive Effect of Natural and Synthetic Antioxidants on Lipid Peroxidation in the Mammalian EyeOphthalmic Research, 1996
- Cis-UROCANIC ACID SYNERGIZES WITH HISTAMINE FOR INCREASED PGE2PRODUCTION BY HUMAN KERATINOCYTES: LINK TO INDOMETHACIN-INHIBITABLE UVB-INDUCED IMMUNOSUPPRESSIONPhotochemistry and Photobiology, 1995
- Enhanced prostaglandin synthesis after ultraviolet injury is mediated by endogenous histamine stimulation. A mechanism for irradiation erythema.JCI Insight, 1990
- Identification of the molecular target for the suppression of contact hypersensitivity by ultraviolet radiation.The Journal of Experimental Medicine, 1989
- Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology.The Journal of Experimental Medicine, 1983